Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.03 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | reachable by antibody | 0.45 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 6 Parkinson's papers of 164 | 0.74 |
| pathways Reactome | 2 pathways; mostly dopamine synapse | 1.00 |
No case: the score is under the bar. Receipt 6789
Sealed predictions
- RTN3 in dopamine neurons, braak+0.37 (p 0.329) → +0.11 (p 0.787)receipt 6795
Swarm cases
receipt 6795: RTN3 in dopamine neurons, braak
- power
- full sample +0.27 (p 0.277, n 18), 95% CI -0.22 to +0.65. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.30 (p 0.232, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.45 (p 0.060, n 18). could be the mix.
- skeptic
- leave-one-out range +0.18 to +0.38, sign flips 0; without severely affected donors +0.27 (p 0.277, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for RTN3 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts